CBER Will Devote More Time To Non-COVID-19 Work Beginning In Six Months
Executive Summary
Center for Biologics and Evaluation and Research is to resume normal operations at the beginning of 2023 and will stop prioritizing resources for COVID-19 regulatory work over non-COVID-19 matters.